Sarcopenia Predicts Outcomes After Lung Transplantation in Older Lung Transplant Candidates
- Ashley Hu 1, Ashley Prosper 1, Kathleen Ruchalski 1, Christian Fulinara 2, Alina Huynh 2, David Sayah 3, Stephen S Weigt 3, Jonathan Singer 4, Abbas Ardehali 5, Reshma Biniwale 5, Deena Goldwater 6, Joanna Schaenman 2
- 1Department of Radiology, David Geffen School of Medicine at UCLA, Los Angeles, California.
- 2Division of Infectious Diseases, David Geffen School of Medicine at UCLA, Los Angeles, California.
- 3Division of Pulmonary Medicine, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California.
- 4Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, UCSF, San Francisco, California.
- 5Department of Cardiothoracic Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California.
- 6Division of Geriatrics, David Geffen School of Medicine at UCLA, Los Angeles, California.
- 0Department of Radiology, David Geffen School of Medicine at UCLA, Los Angeles, California.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Objective evaluation of aging is crucial for lung transplantation (LT) in older adults. Sarcopenia, a measure of muscle loss, correlates with frailty and impacts post-LT hospital stay, aiding risk stratification.
Area Of Science
- Gerontology
- Transplantation Medicine
- Radiology
Background
- Lung transplantation (LT) is increasingly performed in older recipients.
- Objective methods to assess aging are needed to optimize post-LT outcomes.
- Frailty and sarcopenia show promise in predicting clinical outcomes.
Purpose Of The Study
- To evaluate sarcopenia and frailty as objective measures of aging in older lung transplant candidates.
- To determine the association between sarcopenia, frailty, and post-transplantation outcomes.
Main Methods
- Eighty-four patients over 55 undergoing LT evaluation were enrolled.
- Sarcopenia was assessed using pre-transplantation chest CT scans (pectoralis major muscle area and attenuation).
- Frailty was measured using the Fried Frailty Phenotype (FFP) and Short Performance Physical Battery (SPPB).
Main Results
- 63% of patients were frail/prefrail by SPPB; 53% by FFP.
- Sarcopenia correlated with frailty (FFP: P=.004; SPPB: P=.044).
- Sarcopenia was significantly associated with shorter length of stay (median 12 vs. 21 days) and reduced total hospital time in the first year post-LT.
Conclusions
- A comprehensive evaluation including sarcopenia and frailty can improve risk stratification in older LT candidates.
- Optimizing organ allocation based on these assessments can enhance LT outcomes.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

